Last Updated: 19 Sep 2024
Executive Summary
American Healthcare REIT, Inc. (AHR) is a real estate investment trust (REIT) that invests in healthcare-related properties. The company's portfolio consists of 142 properties located in 34 states. AHR's tenants include hospitals, medical office buildings, and skilled nursing facilities.
The company's latest stock price is $24.53. AHR has a market capitalization of $3.26 billion and an EBITDA of $303.06 million. The company's book value is $14.69 per share and its dividend yield is 0.0408%.
AHR's financial performance has been mixed in recent quarters. The company's revenue grew by 9.2% in the latest quarter, but its earnings per share declined by 52%. AHR's operating margin is 6.09% and its return on assets is 1.24%.
Company Overview
AHR was founded in 1998 and is headquartered in Irvine, California. The company's portfolio of healthcare-related properties includes hospitals, medical office buildings, skilled nursing facilities, and other healthcare-related facilities. AHR's tenants are typically healthcare providers, such as hospitals, physicians, and nursing homes.
The company's investment strategy is to acquire and lease healthcare-related properties that are located in markets with strong demographics and a growing demand for healthcare services. AHR's portfolio is geographically diversified, with properties located in 34 states.
Fundamental Analysis
AHR's financial performance has been mixed in recent quarters. The company's revenue grew by 9.2% in the latest quarter, but its earnings per share declined by 52%. AHR's operating margin is 6.09% and its return on assets is 1.24%.
The company's financial leverage is moderate, with a debt-to-equity ratio of 0.54. AHR's interest coverage ratio is 2.5x, which indicates that the company has sufficient cash flow to cover its interest payments.
Technical Analysis
AHR's stock price has been trending higher in recent months. The stock is currently trading above its 50-day and 200-day moving averages. The relative strength index (RSI) is 65, which indicates that the stock is overbought.
The stock's support level is $22.50 and its resistance level is $26.00.
Short Term Outlook
AHR's stock price is expected to continue to trend higher in the short term. The stock is currently trading above its 50-day and 200-day moving averages and the RSI is 65, which indicates that the stock is overbought.
The stock's support level is $22.50 and its resistance level is $26.00.
Long Term Outlook
AHR's long-term outlook is positive. The company's portfolio of healthcare-related properties is well-diversified and located in markets with strong demographics and a growing demand for healthcare services.
AHR's financial leverage is moderate and the company's interest coverage ratio is 2.5x, which indicates that the company has sufficient cash flow to cover its interest payments.
Analyst Recommendations
AHR is rated "Buy" by 6 analysts and "Hold" by 2 analysts. The average analyst target price is $21.71.
